EATG and other members of the European Alliance for Responsible R&D and Affordable Medicines have joined their voices in the Joint Rome Declaration to raise awareness and concerns on the most pressing issues related to access to affordable medicines, including the EU’s Pharmaceutical Strategy
The members of the European Alliance for Responsible R&D and Affordable Medicines have joined their voices in the Joint Rome Declaration to raise awareness and concerns on the most pressing issues related to access to affordable medicines, including the EU’s Pharmaceutical Strategy.
The COVID-19 outbreak has shown that the quest for equitable access to medicines facilitated by a fairer biomedical R&D system still remain work in progress. It is time for global, European and national legislators to bring balance to the current system of pharmaceutical incentives so that it serves the public interest via a patient-centered approach. to:
We are confident that policymakers will prioritise health to enable real learning from recent crises.
Shall you have any inquiries, please don’t hesitate to contact Alba Gil (), Junior Policy Manager for Healthcare Delivery at the European Public Health Alliance (EPHA)
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.